Scroll Back to Top

Study number 8530-848

Healthy Overweight Adults, age 18-65

Dates

Jun 09 2024-Dec 03 2024

Location

Dallas, Texas

Age

18-65

Gender

Both

Compensation

$17,665

Group

B2

Study Details

The investigational drug in this research study is being developed for the treatment of obesity.

The purpose of this study are to look at:

  • How well the study drugs are tolerated and any side effects of the study drugs
  • The effect of the study drugs on body weight
  • How much of the study drug gets into the blood stream and how long it takes the body to get rid of it when given tirzepatide is an investigational drug that has been approved by the FDA for the treatment of type 2 diabetes mellitus and chronic weight management. The use of tirzepatide in this study is investigational.

 

Fortrea Dallas, TX is recruiting for:

-Healthy Overweight Men and Women, age 18-65

-Body Mass Index between 27-45

-Study involves multiple overnight stays & outpatient visits

-Compensation up to $17,665 may be provided for time and participation

-Refer a friend to receive $300 per qualified referral

Additional Details

Cohort B2:

Check-in: Jun 9

Check-out: Jun 14

Check-in: Jun 17

Check-out: Jun 18

Check-in: Jun 24

Check-out: Jun 25

Check-in: Jul 1

Check-out: Jul 2

Check-in: Jul 8

Check-out: Jul 9

Check-in: Jul 15

Check-out: Jul 16

Check-in: Jul 22

Check-out: Jul 23

Check-in: Jul 29

Check-out: Jul 30

Check-in: Aug 5

Check-out: Aug 6

Check-in: Aug 12

Check-out: Aug 13

Check-in:  Aug 19

Check-out: Aug 20

Check-in: Aug 26

Check-out: Aug 27

Check-in: Sep 2

Check-out: Sep 3

Check-in: Sep 9

Check-out: Sep 10

Check-in: Sep 16

Check-out: Sep 17

Check-in: Sep 23

Check-out: Sep 27 

Outpatient Visits: Oct 8, 22, Nov 5, 19, Dec 3

 

BMI Calculator

Weight

Height

Feet Inches